Osurnia

Osurnia

Indication: For the treatment of acute otitis externa and acute exacerbation of recurrent otitis externa associated with Staphylococcus pseudintermedius and Malassezia pachydermatis.
Active(s): Terbinafine: 10 mg Florfenicol: 10 mg Betamethasone acetate: 1 mg equivalent to Betamethasone base 0.9 mg Excipients: Butylhydroxytoluene (E321) Hypromellose Lecithin Oleic acid Propylene carbonate Glycerol formal
Pack size(s): 20 x 1.2 g, 40 x 1.2 g, 2 x 1.2 g
Documents: SPC get_app

Got More Questions?

keyboard_arrow_up